MITA activation by tumor DNA elicits anti-tumor immunity by type I IFN induction and tumor antigen presentation by DCs [32], whereas MITA-mediated inflammation promotes tumorigenesis in an inflammation-induced skin cancer model [70]. This evidence concerns the gene STING1 and skin cancer.